Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00047814. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multiple Rising-Dose Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the safety, tolerability and pharmacokinetics of 4 weeks therapy with FK788 in subjects with chronic hepatitis C virus (HCV) infection. Also, to assess the effect of FK788 on serum ALT concentration and hepatitis C viral level during therapy and for four weeks following therapy.
Study identification
- NCT ID
- NCT00047814
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 48 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2002 (Type not available)
- Primary completion
- Not listed
- Completion
- Mar 2006 (Actual)
- Last update posted
- Dec 9, 2011
2002 – 2006
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Liver Center Huntington Memorial Hospital | Pasadena | California | 91105 | — |
| Rocky Mount Gastroenterology | Lakewood | Colorado | 80215 | — |
| University of Florida and Shands Hospital | Gainsville | Florida | 32610 | — |
| Liver Center BIDMC - Harvard | Boston | Massachusetts | 02215 | — |
| Gastroenterology and Hepatology | Kansas City | Missouri | 64131 | — |
| Carolinas Center for Liver Disease | Charlotte | North Carolina | 28203 | — |
| Duke University | Durham | North Carolina | 27705 | — |
| Thomas Jefferson University, Gastroenterology and Hepatology | Philadelphia | Pennsylvania | 19107 | — |
| Northwest Medical Specialties, PLLC Infections Limited, P.S. | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00047814, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 9, 2011 · Synced Nov 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.